357.64

2.21% -8.10

West Pharmaceutical Services Inc (WST)

Overview News Price History Option Chain Financials Why WST Down? Discussions Forecast Stock Split Dividend History

West Pharmaceutical Services Inc stock is traded at $357.64, with a volume of 680.19K. It is down -2.21% in the last 24 hours and up +13.72% over the past month. West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Previous Close:

$365.74

Open:

$364.87

24h Volume:

680.19K

Relative Volume:

0.80

Market Cap:

$25.27B

Revenue:

$3.22B

Net Income/Loss:

$542.70M

P/E Ratio:

47.81

EPS:

7.4805

Net Cash Flow:

$458.00M

1W Performance:

+0.83%

1M Performance:

+13.72%

6M Performance:

+27.35%

1Y Performance:

+60.91%

1-Day Range:

$357.10

$366.42

1-Week Range:

$350.66

$367.66

52-Week Range:

$206.80

$367.66

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name

West Pharmaceutical Services Inc

Sector

Healthcare (1100)

Industry

Medical Instruments & Supplies (56)

Phone

(610) 594-2900

Address

530 HERMAN O. WEST DRIVE, EXTON, PA

Employee

10,800

Twitter

@WestPharma

Next Earnings Date

2026-07-23

Latest SEC Filings

WST's Discussions on Twitter

Compare WST vs ISRG, BDX, MDLN, ALC, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WST West Pharmaceutical Services Inc	357.64	25.36B	3.22B	542.70M	458.00M	7.4805
ISRG Intuitive Surgical Inc	432.83	140.84B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	155.54	41.70B	21.37B	1.41B	3.07B	3.9437
MDLN Medline Inc	42.75	33.35B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	68.33	32.72B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	218.40	28.27B	5.54B	1.52B	1.74B	10.37

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Initiated	Morgan Stanley	Equal-Weight
Sep-15-25	Initiated	Rothschild & Co Redburn	Buy
Jun-24-25	Initiated	Barclays	Equal Weight
Mar-18-25	Initiated	Evercore ISI	Outperform
Feb-14-25	Upgrade	Deutsche Bank	Hold → Buy
Jan-08-25	Initiated	Citigroup	Buy
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-12-24	Upgrade	UBS	Neutral → Buy
Feb-07-24	Upgrade	Jefferies	Hold → Buy
Jun-16-23	Upgrade	BofA Securities	Neutral → Buy
Apr-11-23	Upgrade	Stephens	Equal-Weight → Overweight
Dec-14-22	Initiated	Deutsche Bank	Hold
Nov-30-22	Initiated	UBS	Neutral
Oct-28-22	Downgrade	BofA Securities	Buy → Neutral
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Oct-14-20	Initiated	Stephens	Equal-Weight
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Apr-24-20	Upgrade	BofA/Merrill	Underperform → Neutral
Dec-12-19	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-19	Upgrade	BofA/Merrill	Underperform → Neutral
May-01-19	Downgrade	Jefferies	Buy → Hold
Apr-23-19	Initiated	William Blair	Outperform
Apr-25-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-24-18	Initiated	Goldman	Neutral
Oct-17-17	Downgrade	BofA/Merrill	Buy → Neutral
Oct-03-17	Initiated	Stephens	Equal-Weight
Sep-15-17	Upgrade	Jefferies	Hold → Buy
Oct-28-16	Upgrade	Wells Fargo	Market Perform → Outperform
Sep-21-16	Downgrade	Wells Fargo	Outperform → Market Perform
Mar-22-16	Initiated	Wells Fargo	Outperform
May-14-10	Reiterated	UBS	Neutral
Feb-23-10	Initiated	Jefferies & Co	Buy
Dec-19-08	Initiated	UBS	Neutral

View All

West Pharmaceutical Services Inc Stock (WST) Latest News

Jul 02, 2026

KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating - marketscreener.com

Jul 02, 2026

Jul 01, 2026

West Pharmaceutical completes sale of SmartDose 3.5mL system By Investing.com - Investing.com Australia

Jul 01, 2026

Form 4 West Pharmaceutical Services Inc For: 1 July By Investing.com - Investing.com Canada

Jul 01, 2026

West Pharmaceutical (WST) director awarded new phantom stock units and RSUs - Stock Titan

Jul 01, 2026

West Pharmaceutical completes sale of SmartDose 3.5mL system - Investing.com

Jul 01, 2026

West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System - PR Newswire

Jul 01, 2026

West Pharmaceutical Services stock hits 52-week high at 363.38 USD - Investing.com

Jul 01, 2026

Westar™ RS LyoVials from West Pharmaceuticalmodular containment for complex injectables - AD HOC NEWS

Jul 01, 2026

West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Jump On Injectable DemandHas The Bull Case Changed? - Yahoo Finance

Jul 01, 2026

Jun 30, 2026

West Pharmaceutical Services, Inc.'s stock price skyrockets to $359.00, boasting a promising 1.22% increase - Smartkarma

Jun 30, 2026

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 30, 2026

Here's Why You Should Add BrightSpring Stock to Your Portfolio Now - TradingView

Jun 30, 2026

Jun 29, 2026

The SmartDose Gen. II injector from West Pharmaceutical Services Inc.wearable biologics delivery - AD HOC NEWS

Jun 29, 2026

West Pharmaceutical Services Inc. stock rises Monday, still underperforms market - MarketWatch

Jun 29, 2026

West Pharmaceutical focuses on long term growth, shares steady in S&P 500 healthcare segment - AD HOC NEWS

Jun 29, 2026

West Pharmaceutical Services (WST) Stock Analysis: Strong Revenue Growth and Bullish Analyst Ratings Offer Promising Prospects - DirectorsTalk Interviews

Jun 29, 2026

Jun 28, 2026